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Abstract:
Background:
Mood Spectrum Self Report (MOODS-SR) is an instrument that assesses mood spectrum symptomatology including subthreshold
manifestations and temperamental features. There are different versions of the MOODS-SR for different time frames of symptom
assessment: lifetime (MOODS-LT), last-month and last-week (MOODS-LW) versions.
Objective:
To evaluate the psychometric properties of the MOODS-LT the MOODS-LW.
Methods:
The reliability of the MOODS-LT and MOODS-LW was evaluated in terms of internal consistency and partial correlations among
domains and subdomains. The known-group validity was tested by comparing out-patients with bipolar disorder (n=27), unipolar
depression  (n=8)  healthy  controls  (n=68).  The  convergent  and  divergent  validity  of  MOODS-LW  were  evaluated  using  the
Montgomery Åsberg Depression Rating Scale (MADRS), the Young-Ziegler Mania Rating Scale (YMRS) in outpatients as well the
General Health Questionnaire (GHQ-12) in healthy controls.
Results:
Both MOODS-LT and MOOODS-LW showed high internal consistency with the Kuder-Richardson coefficient ranging from 0.823
to  0.985 as  well  as  consistent  correlations  for  all  domains  and subdomains.  The last-week version correlated  significantly  with
MADRS (r= 0.79) and YMRS (r=0.46) in outpatients and with GHQ-12 (r= 0.50 for depression domain, r= 0.29 for rhythmicity) in
healthy controls.
Conclusion:
The Swedish version of the MOODS-LT showed similar psychometric properties to other translated versions. Regarding MOODS-
LW, this first published psychometric evaluation of the scale showed promising psychometric properties including good correlation
to established symptom assessment scales. In healthy controls, the depression and rhythmicity domain scores of the last-week version
correlated significantly with the occurrence of mild psychological distress.
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1. INTRODUCTION
Mood disorders are some of the most prevalent disorders in modern society causing high burden of disease [1].
Despite the high public health impact, the clinical psychopathology of mood disorders and their classifications are still
developing and hence validation and evaluation of measuring instruments is important [2].
The debate on whether mood psychopathology would be best conceptualized by a dimensional approach rather than
a categorical approach is a longstanding one. During the last three decades different attempts to expand the boundaries
of bipolar disorders have been tried, focusing on subthreshold forms of depression and on temperaments [3 - 5]. Several
authors proposed a more dimensional view of mood psychopathology as a complement to the categorical approach of
the  DSM [6  -  8].  Over  the  following  years,  clinicians  and  researchers  of  the  University  of  Pisa,  Italy,  and  of  the
Universities  of  Pittsburgh,  Columbia  (New  York)  and  California  (San  Diego),  promoted  the  “Spectrum  Project
Collaborative Group” (SPCG). Aim of the SPCG was to create and validate instruments able to recognize the wide halo
of  phenomenology  surrounding  the  ‘core’  features  of  each  DSM  mood  category  as  well  as  overcome  the  classic
unipolar/bipolar dichotomy [9]. The latest version of Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
[10] still proposes a discrete nosological dichotomy between major depression and bipolar disorder, whereas efforts to
operationalize  bipolar  subthreshold  syndromes  are  increasingly  made  [11].  On  the  other  hand  other  authors  have
criticized this approach. In particular, some authors have pointed out that boundaries with other psychiatric disorders
may become blurred [12].
The Mood Spectrum Self-Report questionnaire (MOODS-SR) was created and validated by the “SPCG” [13] as a
self-administered adaptation of the Structured Clinical Interview for Mood Spectrum (SCI-MOODS) [14]. With respect
to other validated instrument such as the MDQ, the HCL-32 and the BSDS, the SCI-MOODS and the MOODS-SR aim
to assess not only the typical symptoms of mood disorders but, together with the nuclear aspects, the whole halo of
atypical and subthreshold features that surround the full blown disorders. There are different versions of the MOODS-
SR which address different time frames of symptom assessment: lifetime, last-month and last-week versions.
The lifetime version (MOODS-LT) was designed to assess lifetime occurrence of the typical mood symptoms as
well as a range of clinical features associated with mood psychopathology. The objective of MOODS-LT is to screen
for symptoms which resemble the DSM criteria and, at the same time, considering subthreshold manifestations and
temperamental features which may not reach a diagnostic threshold but have diagnostic and therapeutic significance
[15]. The lifetime version has been validated in English, Italian and Spanish [16].
The last-month (MOODS-LM) and last-week (MOODS-LW) versions were designed to measure changes in mood
spectrum symptomatology over time and provide accurate assessment of recent mood changes which has been shown
for MOODS-LM [17]. To our knowledge, the last-week version has not been previously evaluated.
The aim of this study was to translate and evaluate the psychometric properties of the Swedish adaptation of the
MOODS-SR both for the lifetime and last-week versions. In addition, a sub-analysis of outpatients with unipolar and
bipolar mood disorders was performed to measure the MOODS-SRs ability to discriminate between these. Furthermore,
the correlation was examined between current mild psychological distress, rated with the General Health Questionnaire
(GHQ-12), and the scores of MOODS-LW in healthy controls.
2. METHODS
The study evaluated the psychometric properties of the Swedish adaptation of the MOODS-LT and MOODS-LW
using Classical Test Theory methods. The reliability of the scale was evaluated in terms of internal consistency and
partial correlations among scales domains and subdomains. The known-group validity was tested by comparing the
patient group to a healthy control group without history of psychiatric care.
The convergent and divergent validity of the scale of the last week-version was evaluated using rating scales which
are  considered  to  be  the  ”gold  standard“  in  depression  and  mania  assessment  in  Sweden;  the  Montgomery  Åsberg
Depression Rating Scale (MADRS) and the Young-Ziegler Mania Rating Scale (YMRS). In the control group, the total
score  and  the  domain  scores  in  MOODS-LW  were  correlated  to  the  score  in  the  General  Health  Questionnaire
(GHQ-12).
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2.1. Participants
The total  study  sample  consisted  of  103  adults,  35  patients  with  a  previously  diagnosed  mood disorder  and  68
healthy participants. All subjects provided written informed consent before participating in the study. The study was
reviewed by the Regional Ethical Review Board in Gothenburg (Dnr: 091-12).
The  patient  group  was  recruited  over  a  12-month  period  from  outpatient  services  at  Sahlgrenska  University
Hospital. All patients had an established diagnosis of either bipolar or unipolar mood disorder according to DSM-IV-TR
criteria [18] and had no other significant psychiatric disorder.  Patients were compared with a sample of unselected
controls (n=68) which were recruited during the same time period. The sample consisted mainly of hospital staff and
their  relatives.  All  controls  reported  that  they  had  not  been  diagnosed  or  treated  for  a  psychiatric  disorder.  Self-
assessment with GHQ-12 was conducted to exclude current moderate or severe psychological distress.
2.2. Measures
2.2.1. Demographics
All  participants  completed  a  brief  demographic  questionnaire  which  included  self-reported  items  for  age,  sex,
education, occupation, housing, medication and history of previous or current psychiatric care. Education attainment
was categorized into three levels, primary, secondary and higher. Occupation was defined as working or being able to
work full time, student, retired, receive welfare benefits.
2.2.2. Instruments
2.2.2.1. Mood Spectrum Self-Reported Questionnaire, Lifetime and Last-Week Version (MOODS-LT, MOODS-LW)
MOODS-SR includes 161 items exploring the experience of a range of mood-spectrum symptoms and behaviors
including subthreshold manifestations. The instrument is organized into 3 domains: depression, mania and rhythmicity.
In turn, the mania and depression domains are each divided into 3 subdomains: mood, energy and cognition. 154 items
of the scale assess symptoms from the above domains and responses are coded in a dichotomous way (yes/no). Each
‘’yes’’  answer  counts  as  1  point,  the  final  score  summarizes  these.  The  other  seven  items  explore  the  degree  of
impairment associated with the specific symptoms in each of the subdomains. The scoring algorithm is available at the
website www.spectrum-project.org.
2.2.2.2. Mini International Neuropsychiatric Interview (MINI)
In  the  patient  group,  the  diagnostic  assessment  was  carried  out  with  the  Mini  International  Neuropsychiatric
Interview  (MINI),  version  6.0.0.  MINI  allows  diagnoses  to  be  made  according  to  DSM-IV-TR  criteria  in  a  brief
structured interview. It was used to confirm the unipolar and bipolar disorder as well as to exclude other comorbidities
of significance. All interviews were conducted by experienced clinicians.
2.2.2.3. Montgomery Åsberg Depression Rating Scale (MADRS)
The 10-item version of the diagnostic questionnaire [19] was used to measure depressive symptoms in the patient
group. Each item is rated on a Likert type scale from 0 to 6. It is a widely used clinical rating scale and is considered to
be gold standard in clinical  research.  Although MADRS covers a range of the depressive symptomatology,  several
symptoms such as atypical features or psychomotor retardation are not included in this instrument. The clinician-rated
scale was preferred from self-rating version as the assessment took place at same time as other assessments.
2.2.2.4. Young-Ziegler Mania Rating Scale (YMRS)
The YMRS [20] is frequently used to assess manic symptoms. It consist of 11 items where four items are graded on
0 to 8 scale (irritability, speech, thought content, and disruptive/aggressive behavior), while the remaining seven items
are graded on a 0 to 4 scale. Information for assigning scores is gained from the patient’s subjective reported symptoms
over the previous 48 hours and from clinical observation during the interview. It was administrated in conjunction with
MADRS. The MADRS and YMRS interviews were conducted by the authors trained and certified in the use of study
instruments, prior to the administration of the MOODS-SR questionnaires.
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2.2.2.5. General Health Questionnaire-12 (GHQ-12)
GHQ-12 is a self-administered screening tool designed to detect current mental disturbances and disorders [21]. It
assesses changes in mood, feelings, and behaviors as breaks in normal functioning rather than lifetime traits. The scale
has showed great psychometric properties even in a cross-cultural context [22]. It focuses on the last four weeks and
covers mostly disorders or patterns of adjustment associated with distress. Respondents reply on a four-point response
for each item: ‘not at all’ (0), (for questions 1, 3, 4, 7, 8 and 12): ‘better than usual’ (0), ‘same as usual’ (1), ‘rather
more than usual’ (2), ‘much more than usual’ (3). Half the replies have positive direction (“better than usual”) and half
have negative direction (“worse than usual”) [23].
Two  scoring  methods  were  used  in  this  study.  In  the  screening  phase  the  binary  scoring  method  (0-0-1-1,  1
indicating ‘worse’ or ‘much worse than usual’.) was used [24]. A cut-off of 5 or more was used to exclude subjects with
moderate or severe psychological distress while allowing an evaluation of mood spectrum in the control sample. In
statistical analysis, we used the 0-1-2-3 scoring method.
2.3. Statistical Analysis
When comparing two groups, continuous variables were analyzed by t-test and categorical variables by χ2 analysis.
In all calculations, two-tailed p-values <0.05 were considered statistically significant. Kunder-Richardson coefficient, a
variant of the alpha coefficient [25], was used to test the internal consistency of the domains and subdomains and also
the  total  score  of  both  versions  of  the  scale.  Convergent  and  divergent  validity  was  analyzed  using  Pearson’s  r
correlation.  They were  measured  by  comparing  to  MADRS and YMRS for  the  patient  group.  In  the  control  group
domains and subdomains scores of MOODS-LW were compared to the GHQ-12 score.
The known-groups validity was examined for the bipolar and unipolar patients in comparison to control group. It
was  assessed  by  examining  the  between-groups  differences  for  each  domain  using  Kruskal-Wallis  test.  Post  hoc
comparisons  were  conducted  with  the  Games-Howell  test  as  the  data  did  not  meet  the  homogeneity  of  variances
assumption. We excluded from analysis the score of a domain if the subject had more than 12% missing values in the
given  domain.  That  is  a  maximum  of  1  missing  value  in  energy  subdomains  and  3  missing  values  in  the  other
subdomains. Analyses were carried out using SPSS version 22.0 (SPSS Inc. Chicago, IL, USA).
3. RESULTS
The patient group (n=35) and the control group (n=68) did not differ statistically in age, sex distribution, education
level  or  marital  status.  However,  employment  and  own  housing  rate  was  higher  among  controls  (Table  1).  No
participants  were  excluded  from  analysis  after  recruitment.
Table  1.  Demographic  characteristics  of  the  sample.  Continuous  variables  shown  as  mean  ±  standard  deviation  and







Female 26 (74) 46 (68) 0.49
Mean age (years) 40 ± 11 41 ± 13 0.70
Education Primary school 3 (10) 1 (2) 0.09
Secondary school 8 (28) 14 (21)
Higher education 18 (62) 51 (77)
Marital status Single 14 (48) 20 (30) 0.92
Married/cohabiting 15 (52) 46 (70)
Occupation Employed/ Work-seeker 15 (52) 61 (92) <0.001
Student 2 (7) 3 (5)
Retired 4 (14) 2 (3)
Welfare/sickness benefit 8(27) 0
Housing Renting 16 (55) 29 (44) 0.006
Own house/apartment 11 (38) 36 (55)
Other 2 (7) 1 (1)
The diagnoses of the patients were; Bipolar disorder Type I (n=10), 10 Bipolar disorder Type II (n=10), Bipolar
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disorder Not Otherwise Specified (NOS) (n=7) and unipolar depression (n=8). All patients were currently treated with
specific drugs following the current clinical guidelines for mood disorders. All bipolar patients had at least one mood
stabilizing medication prescribed. Less than 6% of all values were missing in the MOODS-LT (2.35%) and MOODS-
LW (5.65%).
3.1. Internal Consistency and Known-Group Validity
Internal consistency was high for all domains on both MOODS-LT and MOODS-LW indicating a high level of
homogeneity  among  items  in  the  scale.  All  the  reliability  values  for  the  MOODS-LT  were  higher  than  0.9  which
implies  excellent  reliability  both  for  the  total  score  and  each  of  domains  and  subdomains  (Table  2).  Homogeneity
among items in each domain were lower (0.823-0.977) for MOODS-LW but still very good (Table 3).
Table 2. MOODS lifetime version. Internal consistency, mean scores (± SD) of the domains, between groups differences and























Depression 0.975 44.6 ± 12.7 46.5 ± 11.3 38.1 ± 15.6 16.4 ± 12.9 45.60 b>c, u>c
mood 0.938 19.8 ± 4.8 20.6 ± 4.5 17.2 ± 5.2 8.8 ± 6.4 45.07 b>c, u>c
energy 0.905 7.2 ± 2.6 7.5 ± 2.4 6.3 ± 2.9 2.7 ± 2.6 38.15 b>c
cognition 0.953 17.8 ± 6.5 18.7 ± 5.8 14.7 ± 8.2 5.5 ± 5.4 44.70 b>c, u>c
Mania 0.970 35.2 ± 14.4 40.1 ± 11.1 16.3 ± 9.3 15.4 ± 13.1 39.49 b>c, b>u
mood 0.935 16.5 ± 6.2 18.6 ± 4.8 8.4 ± 3.6 7.4 ± 6.3 38.32 b>c, b>u
energy 0.913 8.0 ± 3.4 9.2 ± 2.6 3.3 ± 2.3 3.2 ± 4.0 37.19 b>c, b>u
cognition 0.913 10.6 ± 5.8 12.3 ± 4.9 4.8 ± 4.6 4.5 ± 4.6 32.11 b>c, b>u
Rhythmicity 0.902 18.0 ± 4.5 19.0 ± 4.0 14.3 ± 4.8 9.8 ± 6.1 34.68 b>c
Total score 0.985 97.4 ± 28.6 105.1 ± 24.0 65.4 ± 24.4 42.3 ± 27.4 41.85 b>c, b>u
SD= Standard Deviation; KR= Kuder-Richardson Coefficient; b= Bipolar Group; u= Unipolar Group; c= Control Group.
Regarding known-group validity of both versions of the scale mean scores of each domain and total score were
significantly  different  between  patient  and  control  groups  (P<0.001).  In  the  sub-analysis  by  unipolar  and  bipolar
diagnoses both mean ranks of the domains and subdomains were significantly different across the diagnostic groups (P<
0.001) (Table 2 for MOODS-LT and Table 3 for MOODS-LW). Pairwise comparisons between groups (Table 2 for
MOODS-LT and Table 3 for MOODS-LW) showed that bipolar patients had higher mean scores than the control group
in each domain and subdomain (P< 0.005). In the lifetime version, the bipolar group rated significantly higher in all
manic subdomains compared to the unipolar patients. Furthermore, the unipolar group rated significantly higher in all
depressive subdomains of both versions compared to the control group except the energy subdomain in lifetime version
(Table 3).




















Depression 0.966 18.3 ± 15.7 15.2 ± 14.0 28.4 ± 17.4 2.7 ± 5.3 36.272 b>c, u>c
mood 0.917 8.1 ± 6.7 6.8 ± 6.0 12.4 ± 7.6 1.4 ± 2.6 35.490 b>c, u>c
energy 0.887 3.4 ± 3.1 2.8 ± 3.0 5.3 ± 3.0 0.6 ± 1.4 29.598 b>c, u>c
cognition 0.926 6.8 ± 6.5 5.7 ± 6.0 10.6 ± 7.3 0.7 ± 2.0 40.098 b>c, u>c
Mania 0.941 10.9 ± 9.5 12.6 ± 9.6 4.7 ± 6.2 5.2 ± 8.2 21.376 b>u>c
mood 0.889 5.7 ± 4.7 6.4 ± 4.8 3.4 ± 3.7 3.0 ± 4.3 15.104 b>c



















energy 0.837 2.4 ± 2.8 2.7 ± 3.0 0.9 ± 2.3 1.4 ± 2.5 21.224 b>c
cognition 0.823 2.9 ± 3.1 3.5 ± 3.1 1.3 ± 1.3 0.7 ± 1.9 15.445 b>c
Rhythmicity 0.869 9.3 ± 4.2 8.8 ± 3.7 10.6 ± 5.5 2.9 ± 3.9 33.571 b>c, u>c
Total score 0.977 37.6 ± 23.1 36.3 ± 21.5 42.3 ± 29.6 10 ± 14.2 32.578 b>c
SD= Standard Deviation; KR= Kuder-Richardson Coefficient; b= Bipolar Group; u= Unipolar Group; c= Control Group.
3.2. Correlations Among MOODS-SR Domains and Subdomains
Partial correlations among the rhythmicity, manic and depressive domains and their subdomains were significantly,
positively correlated except the correlation between energy-depressive (e-d) and cognitive-manic (c-m) subdomain in
the MOODS-LW (P=0.10) (Table 4 for MOODS-LT and Table 5 for MOODS-LW).
Table 4. Correlations among the domains and subdomains of the MOODS-SR lifetime version.
D M m-d m-m e-d e-m c-d c-m Rh
D 1
M 0.75** 1
m-d 0.97** 0.66** 1
m-m 0.75** 0.95** 0.68** 1
e-d 0.92** 0.74** 0.85** 0.72** 1
e-m 0.68** 0.87** 0.59** 0.75** 0.71** 1
c-d 0.97** 0.71** 0.89** 0.70** 0.87** 0.64** 1
c-m 0.65** 0.93** 0.56** 0.83** 0.65** 0.73** 0.62** 1
Rh 0.83** 0.72** 0.79** 0.72** 0.82** 0.63** 0.81** 0.66** 1
* p< 0.05; ** p< 0.01. D= Depression Domain; M= Mania Domain; m-d= Mood Depressive; m-m= Mood Manic; e-d= Energy Depressive; e-m=
Energy Manic; c-d= Cognition Depressive; c-m= Cognition Manic; Rh= Rhythmicity.
Table 5. Correlations among the domains and subdomains of MOODS-SR last-week version.
D M m-d m-m e-d e-m c-d c-m Rh
D 1
M 0.46** 1
m-d 0.98** 0.48** 1
m-m 0.46** 0.96** 0.49** 1
e-d 0.92** 0.37** 0.85** 0.39** 1
e-m 0.51** 0.87** 0.52** 0.79** 0.46** 1
c-d 0.97** 0.40** 0.92** 0.41** 0.85** 0.48** 1
c-m 0.24* 0.88** 0.27** 0.76** 0.17 0.65** 0.22* 1
Rh 0.71** 0.50** 0.69** 0.47** 0.64** 0.44** 0.70** 0.43** 1
* p< 0.05; ** p< 0.01. D= Depression Domain; M= Mania Domain; m-d= Mood Depressive; m-m= Mood Manic; e-d= Energy Depressive; e-m=
Energy Manic; c-d= Cognition Depressive; c-m= Cognition Manic; Rh= Rhythmicity.
3.3. Convergent and Divergent Validity of MOODS-LW
A strong positive correlation was found between the depressive subdomains of MOODS-LW and MADRS (r =
0.79). A less strong but still significant correlation was found between YMRS and mania domain (r = 0.46) and its
subdomains except the cognition-mania subdomain. These indicate good concurrent validity of the instrument for both
current depression and mania in the patient group (Table 6).In the control group, the scores of MOODS-LW (in each
domain, subdomain and total) were correlated to the presence of mild psychological distress, rated by GHQ-12. The
GHQ-12 score  was  significantly  correlated  with  the  depression  domain  (r=0.50)  and its  subdomains  as  well  as  the
rhythmicity domain (r=0.29) (Table 6). 
(Table ) contd.....
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Depression domains 0.79 <0.01 0.18 0.34 0.50 <0.01
mood 0.72 <0.01 0.18 0.34 0.52 <0.01
energy 0.76 <0.01 0.13 0.51 0.35 <0.01
cognition 0.80 <0.01 0.19 0.33 0.46 <0.05
Mania Domains -0.17 0.34 0.46 <0.05 0.01 0.95
mood -0.20 0.25 0.42 <0.05 0.07 0.62
energy 0.54 0.76 0.56 <0.05 0.02 0.88
cognition -0.27 0.13 0.28 0.14 -0.06 0.67
Rhythmicity 0.49 <0.01 0.24 0.26 0.29 <0.01
Total score 0.52 <0.01 0.281 0.18 0.10 0.51
4. DISCUSSION
The present study evaluates the psychometric properties of the Swedish adaptation of two different versions of the
MOODS-SR,  the  lifetime  version  and  the  last-week  version.  The  findings  for  the  lifetime  version  are  in  line  with
previous validation studies which found similar psychometric properties [14, 16, 26]. The patient group (bipolar and
unipolar patients) displayed consistently higher mean scores than the control group in all domains of MOODS-LT. The
bipolar group rated significantly higher in all domains compared to the control group as well as in all manic subdomains
compared to the unipolar patients.
Regarding the last-week version this is the first published psychometric evaluation to our knowledge. In terms of
convergent  and  divergent  validity  the  MOODS-LW  showed  higher  significance  of  correlation  than  MOODS-LT,
especially between depressive domains and MADRS as well as between the manic domains and YMRS. Furthermore,
for healthy controls, there was a correlation between current mild psychological distress and the depression domain, its
subdomains and the rhythmicity domain of the last-week version. Differences in the mean score between MOODS-LT
and MOODS-LW in all the domains indicate some sensibility to change over time of the last-week version, although
further studies are required.
An interesting finding was the statistically significant correlation between the GHQ-12 score and the depressive
subdomains and rhythmicity in MOODS-LW for the control  group.  The finding supports  the spectrum approach to
mood symptomatology in contrast to the categorical as well as the validity of the scale as a screening and measuring
instrument even among subclinical cases.
The usefulness of MOOD-SR in several research fields was shown in a review by Benvenuti et al. [27]. The clinical
utility of the instrument has been previously proved in different clinical samples but still needs to be confirmed in larger
samples. As opposed to the symptom rating scales MADRS and YMRS, the MOODS-SR also assess subthreshold and
atypical traits and symptoms of mood disorders. These manifestations may be neglected by clinicians despite being
significant predictors of quality of life, functioning and the risk of relapses as previously showed [28, 29]. Furthermore,
lifetime mood spectrum symptoms have also been correlated with current maladaptive symptoms of loss in patients
with complicated grief and major depression [30] as well as with the occurrence of post-traumatic stress symptoms [31].
In a recent study, a classification-tree analysis was used to determine the 33 most relevant MOODS-SR items which
discriminate  bipolar  disorder  from unipolar  depression  [32].  These  items could  be  used  as  a  shorter  version  of  the
MOODS-SR primarily as a routine screening instrument in a clinical context [33].
5. LIMITATIONS
Although the sample size was small, the statistical power was sufficient and the results were in line with previous
studies. A more significant limitation of the study was the control group selection process as it was partly a convenience
sample.  However,  the  internal  consistency  was  excellent  and  unlikely  to  be  affected  by  the  selection  process.
Furthermore, most patients showed low symptom levels, as could be expected at routine follow up visits. This affected
mostly the analysis  of  convergent  analysis  and specifically the correlations with YMRS scale.  We would therefore
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caution that the validity and the reliability of the scale cannot be guaranteed for use in patients with moderate or severe
mania.
CONCLUSION
The Swedish version of the MOODS-SR lifetime version is a promising instrument for reliable and valid screening
of  mood  spectrum  psychopathology  in  the  Swedish  population.  Furthermore,  the  last-week  version  showed  also
encouraging  psychometric  properties  including  good  convergent  validity  in  correlation  with  MADRS  and  YMRS.
Current mild psychological distress, rated with GHQ-12, was correlated positively with scoring in the depression and
rhythmicity domains. Further validation studies of last-week version need to be done for evaluating the clinical utility of
the scale and measuring the sensitivity to change during treatment and over time.  
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